Jeffrey Kitch, APRN
Family · Covington, LANPI 1518107275
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.9%), speaking fees and education — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Bayer at 50.2% of the total. Reporting peaked in 2022 at $7,039 and has fallen 87.0% since, to $917 in 2025. Among family clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 429 payments — averaging $29.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$6K
- Johnson & Johnson$738
- Merck$653
- Pfizer$576
- Novo Nordisk$530
- Sanofi-aventis U.S. LLC$429
- plus $3K from 32 others
What the payments were for
- Speaking & faculty fees$5,17041%
- Food & beverage$7,33858%
- Education$1621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 63 | $6,361 |
| Johnson & Johnson | 40 | $738 |
| Merck | 34 | $653 |
| Pfizer | 40 | $576 |
| Novo Nordisk | 35 | $530 |
| Sanofi-aventis U.S. LLC | 20 | $429 |
| E.r. Squibb & Sons, L.L.C. | 23 | $424 |
| Amarin Pharma, Inc. | 22 | $356 |
| Actelion Pharmaceuticals US, Inc. | 15 | $341 |
| Novartis | 20 | $251 |
| Abbott | 11 | $240 |
| Esperion Therapeutics, Inc. | 15 | $219 |
| Regeneron Healthcare Solutions, Inc. | 10 | $217 |
| Amgen | 22 | $216 |
| Boehringer Ingelheim | 10 | $146 |
| Kowa Pharmaceuticals America, Inc. | 8 | $125 |
| Astellas Pharma US Inc | 2 | $102 |
| Vifor Pharma, Inc. | 4 | $90 |
| AstraZeneca | 7 | $86 |
| Tactile Systems Technology Inc | 5 | $83 |
| Angiodynamics, Inc. | 1 | $65 |
| Boston Scientific | 2 | $44 |
| Baxter Healthcare | 1 | $43 |
| Edwards Lifesciences | 2 | $38 |
| Philips North America LLC | 2 | $37 |
| Medtronic | 2 | $37 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $29 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $28 |
| Atricure, Inc. | 1 | $26 |
| Contego Medical, Inc | 1 | $22 |
| GSK | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $15 |
| Silk Road Medical, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Kestra Medical Technology Services, Inc. | 1 | $13 |
| Irhythm Technologies, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,671 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 297 | $253,148 |
| XareltoRivaroxaban | 164 | $134,568 |
| Repatha SureclickEvolocumab | 105 | $92,287 |
| MounjaroTirzepatide | 56 | $70,575 |
| JardianceEmpagliflozin | 58 | $61,939 |
| OzempicSemaglutide | 29 | $32,801 |
| FarxigaDapagliflozin Propanediol | 34 | $31,523 |
| EntrestoSacubitril/Valsartan | 21 | $24,212 |
| WegovySemaglutide | 15 | $23,383 |
| MultaqDronedarone Hcl | 19 | $19,881 |
| KerendiaFinerenone | 11 | $19,634 |
| MyrbetriqMirabegron | 29 | $16,381 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $15,112 |
| VascepaIcosapent Ethyl | 20 | $13,178 |
| NexlizetBempedoic Acid/Ezetimibe | 12 | $9,885 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $576 | $253,148297 claims |
| Johnson & JohnsonXarelto | $738 | $134,568164 claims |
| Lilly USA, LLCMounjaro | $14 | $70,57556 claims |
| Boehringer IngelheimJardiance | $146 | $61,93958 claims |
| Novo NordiskOzempic, Wegovy | $530 | $56,18444 claims |
| AstraZenecaFarxiga, Symbicort | $86 | $36,48751 claims |
| NovartisEntresto | $251 | $24,21221 claims |
| Sanofi-aventis U.S. LLCMultaq | $429 | $19,88119 claims |
| BayerKerendia | $6,361 | $19,63411 claims |
| Astellas Pharma US IncMyrbetriq | $102 | $16,38129 claims |
| Esperion Therapeutics, Inc.Nexlizet, Nexletol | $219 | $15,20524 claims |
| GSKTrelegy Ellipta | $17 | $15,11218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,610 family providers in Louisiana.
Other family in Covington
- Karolina RuthnerCovington$17K
- Pamela EganCovington$15K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.